Skip to main content
Niagen Bioscience, Inc. logo

Niagen Bioscience, Inc. — Investor Relations & Filings

Ticker · NAGE ISIN · US1710774076 LEI · 529900OPI7B8JPXCVS70 US Manufacturing
Open in API
Filings indexed 954 across all filing types
Latest filing 2008-02-20 Annual Report
Country US United States of America
Listing US NAGE

About Niagen Bioscience, Inc.

https://www.niagenbioscience.com/

Niagen Bioscience, Inc. (formerly ChromaDex) is a bioscience company focused on the science of nicotinamide adenine dinucleotide (NAD+). The company aims to improve healthspan and support healthy aging by developing products that restore and optimize cellular NAD+ levels. Its core proprietary ingredient is Niagen®, a patented and clinically studied form of nicotinamide riboside (NR), a precursor to NAD+. Niagen® is the key component in the company's consumer dietary supplement brand, Tru Niagen®, and is also developed for the food, beverage, and pharmaceutical markets. The company's research is supported by numerous human clinical studies, a portfolio of over 50 owned and licensed patents, and collaborations with global research institutions.

Recent filings

Filing Released Lang Actions
MAINBODY
Annual Report Classification · 100% confidence The document is titled 'FORM 10-KSB' and is described as an 'ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934' for the fiscal year ended November 30, 2007. It contains detailed sections typical of an annual report, including Description of Business, Legal Proceedings, Market for Common Equity, Management's Discussion and Analysis, and Financial Statements. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The presence of comprehensive financial and operational information confirms it is the official annual report filing. Therefore, the correct classification is Annual Report (10-K).
2008-02-20 English
MAINBODY
Interim / Quarterly Report Classification · 100% confidence The document is titled 'FORM 10-QSB' and is a quarterly report pursuant to the Securities Exchange Act of 1934 for the quarterly period ended August 31, 2007. It contains detailed unaudited financial statements including balance sheets, statements of operations, stockholders' equity, cash flows, and notes to financial statements. The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement. The presence of financial data and analysis for the quarter confirms it is an interim financial report. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2007-10-15 English
MAINBODY
Interim / Quarterly Report Classification · 100% confidence The document is titled 'FORM 10-QSB' and is a quarterly report pursuant to the Securities Exchange Act of 1934 for the quarterly period ended May 31, 2007. It contains detailed unaudited financial statements including balance sheets, statements of operations, stockholders' equity, cash flows, and notes to financial statements. The document is approximately 15,000 characters long, indicating it is a full report rather than a brief announcement. The presence of financial statements and detailed management discussion confirms it is an interim quarterly report. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2007-07-20 English
MAINBODY
Regulatory Filings Classification · 100% confidence The document is a Form 12b-25, which is a Notification of Late Filing submitted to the SEC. It specifically states that the company was unable to file its periodic report (Form 10-QSB) on time and requests an extension. The document does not contain actual financial data or the report itself but is a regulatory notification about the delay in filing. According to the rules, such officer certifications or notifications about filing delays should be classified as Regulatory Filings (RNS). The document length is under 5,000 characters and it is clearly not the report but a notification about the report's late filing.
2007-07-13 English
MAINBODY
Interim / Quarterly Report Classification · 100% confidence The document is titled 'FORM 10-QSB' and is filed with the SEC, indicating it is a quarterly report. It covers the quarterly period ended February 28, 2007. The document includes detailed unaudited financial statements such as balance sheets, income statements, statements of cash flows, and notes to financial statements. It also contains management's discussion of accounting policies and other financial information typical of an interim or quarterly report. The length of the document (15,000 characters) and the presence of substantive financial data confirm it is the actual report, not just an announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2007-04-17 English
MAINBODY
Regulatory Filings Classification · 100% confidence The document is a Form 12b-25, which is a Notification of Late Filing submitted to the SEC. It specifically references a late filing of a Form 10-QSB quarterly report for the period ended February 28, 2006. The text explains the reason for the delay and requests an extension to file the report. There are no actual financial statements or substantive financial data included in this document; it is purely a notification about the late filing of a quarterly report. According to the rules, such a notification is a Regulatory Filing (RNS) because it is a compliance document related to filing deadlines and does not contain the report itself or detailed financial data.
2007-04-16 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.